Exosome Diagnostics, a Bio-Techne (NASDAQ:TECH) brand, has completed validation testing for COVID-19 and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory.
The SARS-CoV-2 virus testing will be performed in nasal, nasopharyngeal, and bronchoalveolar lavage patient specimens.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.